Hyperkalemia: The Hidden Electrical Threat

(Note: For PDF File Swipe To The End Of Article)

Introduction

The human body depends on a delicate balance of electrolytes to maintain normal nerve impulses, muscle contractions, fluid distribution, and the electrical activity of the heart. Among these electrolytes, potassium plays a particularly important role. Although the body requires potassium in relatively small quantities compared with water, its concentration inside and outside cells must remain within a narrow range.

When potassium levels in the blood rise above the normal range, a condition known as hyperkalemia develops. This disorder may initially produce few or no noticeable symptoms, yet it can interfere with the electrical conduction system of the heart. In severe cases, hyperkalemia can lead to dangerous arrhythmias, cardiac arrest, and death if not recognized and treated promptly.

Hyperkalemia is especially important in people with chronic kidney disease, acute kidney injury, diabetes mellitus, heart failure, or certain medication exposures. It may also occur after severe tissue injury, during some endocrine disorders, or when potassium shifts from inside cells into the bloodstream.

The challenge is that the severity of hyperkalemia cannot always be determined by symptoms alone. Some patients with substantially elevated potassium feel relatively well, while others develop serious cardiac abnormalities. An electrocardiogram (ECG), laboratory investigations, clinical assessment, and evaluation of the underlying cause are therefore essential.

This article explores hyperkalemia from basic physiology to advanced clinical management. It discusses the definition, causes, classification, pathophysiology, signs and symptoms, ECG changes, diagnostic approach, emergency treatment, nursing responsibilities, dietary considerations, complications, prevention, and long-term follow-up.

The aim is to provide a comprehensive educational resource for medical students, nurses, healthcare professionals, and readers interested in understanding this potentially life-threatening electrolyte disorder.

1. What Is Hyperkalemia?

Hyperkalemia is an abnormally elevated concentration of potassium in the blood. Potassium is an essential mineral and electrolyte that supports the normal functioning of the heart, skeletal muscles, smooth muscles, and nervous system.

In many laboratories, the normal serum potassium range is approximately 3.5–5.0 mmol/L, although the reference range varies slightly between laboratories. Hyperkalemia is commonly defined as a serum potassium concentration above the laboratory's upper reference limit.

For clinical discussion, hyperkalemia is often categorized as follows:

• Mild hyperkalemia: approximately 5.1–5.5 mmol/L.
• Moderate hyperkalemia: approximately 5.6–6.0 mmol/L.
• Severe hyperkalemia: above 6.0 mmol/L in many clinical classifications.

These categories are not completely universal. Some clinical protocols define severe hyperkalemia as potassium of 6.5 mmol/L or higher. The urgency of treatment also depends on how rapidly potassium has risen, whether ECG abnormalities are present, the patient's kidney function, and the overall clinical situation.

A potassium level that appears only moderately elevated may still be dangerous when it rises quickly or when the patient has additional cardiac risk factors.

Hyperkalemia is therefore not simply a laboratory abnormality. It is a potentially serious disorder that requires interpretation in the context of the individual patient.

2. Understanding Potassium and Its Importance

Potassium is one of the body's major electrolytes. It carries an electrical charge when dissolved in body fluids and helps regulate the movement of electrical signals across cell membranes.

Approximately 98% of the body's potassium is located inside cells, particularly in skeletal muscle cells. Only a small proportion circulates in extracellular fluid, including blood plasma.

This distribution is maintained by cellular transport mechanisms, especially the sodium-potassium ATPase pump. The pump uses energy to move potassium into cells and sodium out of cells.

Although only a small amount of potassium is present in the bloodstream, changes in its extracellular concentration can significantly affect the electrical behavior of excitable tissues.

Major functions of potassium

1. Maintaining cardiac electrical activity

Potassium helps regulate the resting membrane potential of cardiac cells. Changes in extracellular potassium can alter cardiac depolarization and repolarization, affecting the heart rate and rhythm.

2. Supporting skeletal muscle contraction

Normal potassium concentrations are necessary for the electrical signals that stimulate skeletal muscles. Significant abnormalities may cause weakness, fatigue, or paralysis.

3. Supporting nerve function

Nerve cells depend on controlled changes in membrane electrical potential to transmit impulses. Potassium disturbances can interfere with normal nerve and muscle responses.

4. Maintaining acid-base balance

Potassium distribution is influenced by acid-base status and cellular ion exchange. Certain forms of metabolic acidosis may contribute to increased extracellular potassium, although the relationship depends on the cause of acidosis.

5. Supporting cellular metabolism

Potassium is involved in enzyme activity, cellular processes, and the normal functioning of many tissues.

6. Contributing to fluid and electrolyte balance

Potassium works alongside sodium, chloride, bicarbonate, and other electrolytes to maintain the body's internal environment.

The body must regulate potassium carefully because both low and high potassium levels can impair cardiac and neuromuscular function.

3. How the Body Normally Regulates Potassium

Potassium balance depends on three major processes: intake, movement between intracellular and extracellular compartments, and elimination from the body.

A. Dietary intake

Potassium enters the body through food, beverages, supplements, and certain medications. Foods such as beans, lentils, potatoes, tomatoes, fruit, dairy products, and leafy vegetables can provide substantial amounts.

Under normal conditions, the kidneys adapt their potassium excretion to changes in dietary intake. The digestive tract also contributes to potassium elimination.

B. Movement into and out of cells

The majority of potassium is stored inside cells. Insulin and beta-2 adrenergic stimulation generally promote the movement of potassium from the extracellular space into cells.

When these mechanisms are impaired, or when potassium is released from damaged cells, the concentration in the bloodstream may increase.

C. Renal excretion

The kidneys are the principal organs responsible for regulating long-term potassium balance. Potassium is filtered and processed along the renal tubules, where its final excretion is adjusted according to the body's needs.

Aldosterone, a hormone produced by the adrenal glands, promotes potassium secretion in specific parts of the kidney. Reduced aldosterone production or impaired aldosterone action can therefore contribute to hyperkalemia.

When kidney function deteriorates, the body's ability to eliminate potassium may become inadequate, particularly during acute illness or when additional risk factors are present.

4. What Happens During Hyperkalemia?

Hyperkalemia develops when the amount of potassium entering the extracellular fluid exceeds the amount removed, or when potassium shifts from inside cells into the bloodstream.

Three broad mechanisms explain most cases:

• Reduced potassium excretion.
• Increased potassium release or intake that exceeds the body's capacity to eliminate it.
• Abnormal redistribution of potassium from intracellular to extracellular fluid.

More than one mechanism may operate simultaneously. For example, a patient with chronic kidney disease who becomes dehydrated and starts taking a potassium-containing supplement may develop hyperkalemia because renal excretion is reduced while potassium intake increases.

Understanding the mechanism is essential because treatment should address both the elevated potassium concentration and its underlying cause.

5. Causes and Risk Factors of Hyperkalemia

Hyperkalemia can result from kidney disorders, medications, endocrine abnormalities, tissue injury, metabolic disturbances, or excessive potassium intake in susceptible individuals.

A. Kidney disease

Kidney dysfunction is one of the most important causes of hyperkalemia.

Chronic kidney disease (CKD) progressively reduces the kidneys' ability to maintain electrolyte balance. Patients with advanced CKD are particularly vulnerable, although hyperkalemia can also occur in earlier stages when additional risk factors are present.

Acute kidney injury (AKI) may cause potassium to accumulate rapidly because renal filtration and excretion suddenly deteriorate. AKI can develop during dehydration, severe infection, shock, urinary obstruction, or exposure to certain medications.

End-stage kidney disease presents an especially high risk when dialysis is missed, delayed, or insufficient to remove the potassium accumulating between treatments.

B. Medications

Several medications can increase serum potassium. This does not mean that every patient taking these medicines will develop hyperkalemia. The risk depends on kidney function, dose, other medications, and individual susceptibility.

Important examples include:

• ACE inhibitors: Such as enalapril and lisinopril, which reduce aldosterone production.
• Angiotensin receptor blockers (ARBs): Such as losartan and valsartan, which interfere with angiotensin II signaling.
• Mineralocorticoid receptor antagonists: Such as spironolactone and eplerenone.
• Potassium-sparing diuretics: Such as amiloride and triamterene.
• Nonsteroidal anti-inflammatory drugs (NSAIDs): Such as ibuprofen and naproxen, which may impair renal potassium handling in susceptible patients.
• Trimethoprim-containing antibiotics: Which can reduce renal potassium excretion.
• Heparin: Which may suppress aldosterone production in some circumstances.
• Certain beta-blockers: Which can contribute to elevated potassium in susceptible patients.
• Potassium supplements and potassium-containing salt substitutes: Especially when kidney function is impaired.

Digoxin toxicity and some other medication-related conditions can complicate the assessment of patients with potassium abnormalities.

Important principle: Patients should not independently discontinue prescribed heart or kidney medicines because of a potassium result. Some medications that raise potassium also protect the heart and kidneys. A clinician should assess the risks and benefits and decide whether the dose needs adjustment, temporary interruption, or an alternative strategy.

C. Diabetes mellitus

Diabetes can increase the risk of hyperkalemia through several mechanisms.

Insulin helps move potassium into cells. When insulin levels are very low or insulin action is impaired, potassium may shift toward the extracellular compartment.

Diabetes can also cause chronic kidney disease, which reduces potassium excretion. In addition, diabetic hyporeninemic hypoaldosteronism can impair renal potassium handling.

Diabetic ketoacidosis is a particularly important example. A patient's initial blood potassium may be normal or elevated even when the total amount of potassium in the body is depleted because of urinary losses. Potassium may fall substantially once insulin and fluids are administered.

Therefore, serum potassium alone does not always reflect the body's total potassium stores.

D. Adrenal gland disorders

The adrenal glands produce aldosterone, which helps the kidneys excrete potassium.

Conditions that reduce aldosterone production or action can lead to hyperkalemia.

Examples include:

• Primary adrenal insufficiency, also known as Addison's disease.
• Hypoaldosteronism.
• Certain forms of diabetic kidney disease associated with reduced renin and aldosterone activity.
• Medication-related suppression of aldosterone production or action.

Patients may also have low blood pressure, sodium abnormalities, dehydration, or other features depending on the underlying disorder.

E. Tissue damage and cell breakdown

Potassium is concentrated inside cells. When large numbers of cells are damaged, potassium can be released into the bloodstream.

Important causes include:

Rhabdomyolysis: Severe muscle breakdown releases potassium and other intracellular substances.

Major trauma: Extensive tissue injury may increase potassium release.

Burns: Severe burns can cause cell destruction and disturbances in fluid and electrolyte balance.

Tumor lysis syndrome: Rapid destruction of cancer cells, sometimes following cancer treatment, releases potassium, phosphate, and other intracellular substances.

Hemolysis within the body: Destruction of red blood cells can release intracellular potassium.

These conditions may require urgent treatment because potassium can rise rapidly and other serious metabolic abnormalities may occur at the same time.

F. Metabolic acidosis

Metabolic acidosis may contribute to hyperkalemia, particularly in certain mineral and organic acid disturbances.

However, the relationship is complex. Not all forms of acidosis produce the same degree of potassium movement, and hyperkalemia can occur without acidosis.

The underlying cause of acidosis, kidney function, insulin activity, and tissue injury all influence the final potassium concentration.

G. Excessive potassium intake

A high potassium intake does not usually cause hyperkalemia in people with healthy kidneys and normal hormonal regulation. The kidneys can increase potassium excretion in response to increased intake.

Nevertheless, excessive intake can become dangerous in patients with impaired renal function or reduced aldosterone activity.

Potential sources include:

• Potassium tablets.
• Certain electrolyte supplements.
• Potassium-containing salt substitutes.
• Some oral rehydration or nutrition products, depending on their formulation.
• Large amounts of potassium-containing products when excretion is impaired.

Medication reconciliation should include supplements and nonprescription products, not just prescribed medicines.

H. Reduced kidney perfusion and dehydration

Severe dehydration, blood loss, shock, or conditions that reduce blood flow to the kidneys can cause acute kidney injury.

When filtration and potassium secretion decline, potassium may accumulate. Dehydration can also amplify the effects of medications that affect renal function.

However, dehydration does not invariably produce hyperkalemia; the result depends on the degree of renal impairment, associated losses, and other factors.

I. Urinary obstruction

Obstruction of urinary flow may impair kidney function and potassium excretion. Examples include severe prostate enlargement, obstructing stones, and other conditions that prevent normal urine drainage.

Hyperkalemia may become particularly serious when obstruction causes acute kidney injury.

J. Other causes

Less common or more specialized causes include:

• Familial disorders affecting renal potassium handling.
• Severe infections associated with acute kidney injury or tissue injury.
• Certain chemotherapy-related complications.
• Transfusion-related potassium exposure in specific clinical circumstances.
• Laboratory artifacts that falsely elevate measured potassium.

Identifying the actual cause is essential to prevent recurrence.

6. Classification of Hyperkalemia

Hyperkalemia can be classified according to severity, duration, and mechanism.

A. Classification by serum potassium concentration

Category	Approximate potassium concentration
Normal range	3.5–5.0 mmol/L
Mild hyperkalemia	5.1–5.5 mmol/L
Moderate hyperkalemia	5.6–6.0 mmol/L
Severe hyperkalemia	Above 6.0 mmol/L in many classifications

Laboratory reference ranges and clinical thresholds differ. Some guidelines reserve the term severe hyperkalemia for concentrations of 6.5 mmol/L or above.

These values should not be interpreted in isolation. A rapidly rising potassium concentration, significant ECG changes, or a clinically unstable patient requires urgent attention even if the number does not fit a particular category perfectly.

B. Acute hyperkalemia

Acute hyperkalemia develops over a short period. It may occur during acute kidney injury, severe tissue breakdown, medication toxicity, or metabolic emergencies.

Rapid changes can be especially dangerous because the body has less time to adapt.

C. Chronic hyperkalemia

Chronic hyperkalemia develops or persists over a longer period. It is frequently associated with chronic kidney disease, diabetes, or medications that affect potassium excretion.

Chronic elevation still requires appropriate assessment. A patient who appears well may develop a dangerous increase during an infection, dehydration, medication change, or decline in renal function.

D. True hyperkalemia and pseudohyperkalemia

True hyperkalemia means the potassium concentration in the patient's circulating blood is genuinely elevated.

Pseudohyperkalemia is a falsely high laboratory result caused by factors such as blood sample hemolysis, difficult blood collection, delayed sample processing, or certain abnormalities in blood cell counts.

The distinction matters because treating a falsely elevated result unnecessarily can cause genuine hypokalemia, which is also dangerous.

If the result is unexpected and the patient is stable, clinicians may repeat the sample using appropriate collection and handling procedures. However, repeat testing must not delay emergency treatment when severe hyperkalemia or dangerous ECG changes are suspected.

7. Pathophysiology: How Hyperkalemia Affects the Body

The major danger of hyperkalemia comes from its effect on the electrical properties of cell membranes.

Normally, the potassium concentration is much higher inside cells than outside them. This difference contributes to the resting membrane potential, which is the electrical voltage across the cell membrane when the cell is not actively firing.

When extracellular potassium rises, the potassium concentration gradient becomes smaller. The resting membrane potential becomes less negative.

Initially, this may alter cellular excitability. With more substantial or sustained hyperkalemia, voltage-gated sodium channels may become inactivated, reducing the ability of cardiac and skeletal muscle cells to generate and conduct electrical impulses normally.

The result can include:

• Slower electrical conduction.
• Changes in cardiac depolarization and repolarization.
• Muscle weakness.
• Abnormal heart rhythms.
• Severe conduction disturbances and cardiac arrest.

The ECG manifestations are variable. The same serum potassium concentration may produce different ECG appearances in different patients.

Why the heart is particularly vulnerable

The heart depends on coordinated electrical activation to pump blood effectively. If electrical impulses become too slow, irregular, or disorganized, cardiac output may fall.

Severe hyperkalemia can cause bradycardia, conduction block, ventricular arrhythmias, or asystole. Some patients may deteriorate suddenly without a long period of obvious symptoms.

This explains why suspected severe hyperkalemia is treated as an emergency rather than simply monitored until symptoms develop.

8. Signs and Symptoms of Hyperkalemia

One of the most important clinical features of hyperkalemia is that it may cause no obvious symptoms, even when the potassium concentration is dangerously elevated.

Symptoms depend on the severity, speed of onset, underlying disease, and individual response.

A. Muscle weakness

Patients may describe heaviness in the arms or legs, difficulty climbing stairs, or a general loss of strength.

Muscle weakness can occur because potassium disturbances interfere with the electrical activity of skeletal muscle cells.

B. Fatigue and reduced energy

Some patients experience tiredness, lethargy, or reduced physical endurance.

These symptoms are nonspecific and may result from kidney disease, anemia, infection, medication effects, or other associated conditions rather than hyperkalemia alone.

C. Numbness or tingling

Abnormal sensations may occur in some patients, including tingling or a feeling of reduced sensation.

However, sensory symptoms are not reliable indicators of potassium severity.

D. Nausea and general discomfort

Some patients report nausea, malaise, or feeling generally unwell. These symptoms may reflect the underlying illness rather than the potassium elevation itself.

E. Palpitations

Palpitations are the sensation of a racing, irregular, pounding, or unusually slow heartbeat.

In hyperkalemia, palpitations may indicate a cardiac rhythm disturbance and should be taken seriously, particularly when accompanied by weakness, dizziness, or chest discomfort.

F. Dizziness or fainting

A significant disturbance in heart rate or cardiac output may reduce blood flow to the brain, causing light-headedness, dizziness, or loss of consciousness.

These symptoms require urgent evaluation.

G. Flaccid weakness or paralysis

Severe potassium abnormalities can occasionally cause marked muscle weakness or paralysis. The weakness may progress and can, in some cases, affect respiratory muscles.

Respiratory difficulty or rapidly progressive weakness is a medical emergency.

H. Cardiac symptoms

Severe hyperkalemia can cause:

• A very slow heartbeat.
• Irregular heart rhythms.
• Dizziness or collapse.
• Low blood pressure.
• Chest discomfort in some circumstances.
• Sudden cardiac arrest.

The absence of these symptoms does not exclude a serious potassium disturbance.

9. ECG Changes in Hyperkalemia

The electrocardiogram is a central part of evaluating suspected acute hyperkalemia. It can reveal disturbances in cardiac electrical activity and help determine the urgency of treatment.

However, ECG changes do not reliably correspond to a particular potassium concentration. A normal-looking ECG does not rule out dangerous hyperkalemia.

A. Tall, peaked T waves

One of the classic teaching findings is a tall, narrow, peaked T wave.

This change reflects altered ventricular repolarization. It may occur in early hyperkalemia, although peaked T waves are not present in every patient and can have other causes.

B. Shortened QT interval

Hyperkalemia may shorten the QT interval, particularly in earlier stages. This finding is variable and is not sufficiently reliable to diagnose hyperkalemia by itself.

C. PR interval prolongation

As potassium rises, atrial and atrioventricular conduction may become abnormal. The PR interval may lengthen.

D. Flattening or disappearance of P waves

More substantial hyperkalemia can reduce atrial electrical activity, resulting in smaller P waves or their disappearance.

E. Widened QRS complex

A widened QRS complex may develop as ventricular conduction slows. This is a concerning finding, particularly when associated with other signs of hyperkalemia.

F. Sine-wave pattern

In advanced cases, the QRS complex may merge with the T wave, creating a broad sine-wave appearance.

This pattern indicates profound electrical disturbance and a risk of deterioration into ventricular fibrillation, pulseless electrical activity, or asystole.

G. Bradyarrhythmias and other rhythm disturbances

Severe hyperkalemia may cause profound bradycardia, conduction block, ventricular tachyarrhythmias, or other dangerous rhythms.

Not every patient follows the textbook sequence of ECG changes. Clinical decisions must therefore consider the measured potassium, the patient's condition, and the ECG together.

10. Diagnosis of Hyperkalemia

Diagnosis requires confirmation of elevated potassium when appropriate, evaluation of its severity, identification of the cause, and assessment for complications.

A. Serum potassium measurement

A blood test is the primary method of measuring potassium.

The result should be interpreted with the laboratory's reference range and the clinical situation. If a high result is unexpected, the clinician should consider whether the sample was hemolyzed or affected by collection and processing problems.

B. Repeat potassium testing

A repeat blood sample may be needed when pseudohyperkalemia is suspected.

For example, a patient with normal kidney function and no obvious risk factors may have a mildly elevated potassium result after a difficult blood draw. If the patient is stable and the ECG is not concerning, repeat testing may help establish whether the elevation is genuine.

By contrast, a patient with severe kidney dysfunction, a markedly elevated potassium concentration, or concerning ECG changes requires urgent assessment and treatment. Confirmatory testing should not create an unsafe delay.

C. Electrocardiogram

A 12-lead ECG helps identify conduction abnormalities and arrhythmias.

Continuous cardiac monitoring is commonly required in severe hyperkalemia or when ECG changes, symptoms, or clinical instability are present.

D. Kidney function tests

Serum creatinine, urea, estimated glomerular filtration rate, and other relevant measurements help determine whether impaired kidney function is contributing to potassium accumulation.

Urine output and the patient's recent kidney function trend are also important.

E. Additional electrolyte tests

Other tests may include:

• Sodium.
• Bicarbonate.
• Chloride.
• Calcium.
• Magnesium.
• Phosphate.

These results can help identify accompanying electrolyte or acid-base disturbances.

F. Blood glucose

Glucose testing is especially important in patients with diabetes, suspected ketoacidosis, or those receiving insulin as part of hyperkalemia treatment.

After insulin is administered, repeated glucose monitoring is necessary because treatment-related hypoglycemia can be serious.

G. Blood gas analysis

A venous or arterial blood gas may be indicated when severe metabolic acidosis, respiratory compromise, shock, or a metabolic emergency is suspected.

H. Complete blood count and other investigations

A complete blood count may help identify severe leukocytosis or thrombocytosis, which can contribute to pseudohyperkalemia in certain circumstances.

Creatine kinase may be useful when rhabdomyolysis is suspected. Additional investigations should be guided by the clinical context.

I. Medication and supplement review

The healthcare team should review prescribed drugs, over-the-counter medications, herbal products, potassium supplements, and salt substitutes.

A careful medication history may reveal a preventable cause or an interaction that increased the risk of hyperkalemia.

11. Differential Diagnosis

An elevated potassium result must be interpreted carefully because other conditions may produce similar symptoms or ECG changes.

Important considerations include:

Pseudohyperkalemia: A falsely elevated potassium result caused by sample problems or blood cell abnormalities.

Acute kidney injury: May be both a cause of hyperkalemia and an independent contributor to the patient's illness.

Hypoglycemia: Can cause sweating, confusion, weakness, and altered consciousness, and may occur during hyperkalemia treatment.

Other electrolyte abnormalities: Abnormal calcium or magnesium levels can contribute to cardiac rhythm disturbances.

Acute coronary syndrome: May cause ECG abnormalities, chest discomfort, and hemodynamic instability.

Medication toxicity: Certain drugs can affect heart rate, conduction, kidney function, or potassium balance.

Neuromuscular disorders: Some may produce weakness or paralysis similar to severe potassium disturbances.

The aim is not to choose one diagnosis based on a single symptom. It is to combine history, examination, laboratory results, ECG findings, and clinical response.

12. Complications of Hyperkalemia

The most serious complications involve the cardiovascular and neuromuscular systems.

A. Cardiac arrhythmias

Hyperkalemia can disturb the electrical impulses that coordinate heartbeats. Arrhythmias may range from relatively subtle conduction abnormalities to immediately life-threatening rhythms.

B. Conduction block

Severe potassium elevation can slow conduction through the heart, potentially causing atrioventricular block or other serious conduction disturbances.

C. Ventricular fibrillation

Ventricular fibrillation is a chaotic rhythm in which the ventricles fail to pump blood effectively. Without immediate emergency treatment, it can be fatal.

D. Asystole and cardiac arrest

Advanced hyperkalemia may cause the heart's electrical activity to become profoundly impaired. Cardiac arrest can occur, sometimes with little warning.

E. Severe muscle weakness

Hyperkalemia can interfere with skeletal muscle function and, in severe cases, cause profound weakness or paralysis.

F. Respiratory muscle impairment

If the muscles needed for breathing are severely affected, respiratory failure may develop. This is uncommon but represents a critical complication.

G. Recurrent hyperkalemia

Treatment may temporarily shift potassium into cells without removing it from the body. If the underlying cause persists, potassium can rise again.

This is why successful emergency treatment must be followed by reassessment and a plan to remove excess potassium and prevent recurrence.

13. Emergency Management of Hyperkalemia

Severe hyperkalemia is a medical emergency. Treatment must be guided by trained clinicians using local emergency protocols, appropriate monitoring, and repeated laboratory assessment.

The major treatment objectives are:

1. Protect the heart from dangerous electrical effects.
2. Temporarily lower extracellular potassium by shifting potassium into cells.
3. Remove excess potassium from the body.
4. Treat the underlying cause.
5. Prevent recurrence and treatment-related complications.

These objectives are related but not interchangeable. A medicine that shifts potassium into cells may improve the blood result temporarily without reducing the total amount of potassium in the body.

A. Initial assessment and stabilization

The clinical team assesses the patient's airway, breathing, circulation, blood pressure, mental status, and overall stability.

Important early steps commonly include:

• Obtain urgent blood tests and assess the potassium result.
• Perform a 12-lead ECG.
• Establish cardiac monitoring when indicated.
• Review kidney function and urine output.
• Identify medications or conditions that may be contributing.
• Repeat potassium testing when needed, without delaying urgent treatment in a dangerous presentation.

Patients with severe hyperkalemia, significant ECG changes, or clinical instability require emergency-level care.

B. Intravenous calcium for cardiac membrane stabilization

When significant hyperkalemic ECG changes are present, intravenous calcium is commonly used to stabilize cardiac cell membranes.

Calcium can reduce the immediate risk associated with electrical instability, but it does not lower the potassium concentration itself.

Calcium gluconate is often preferred for peripheral administration because it is less damaging to tissue if extravasation occurs. Calcium chloride contains more elemental calcium per volume and may be selected in particular resuscitation settings according to local protocols and vascular access.

The clinician selects the preparation and dose according to the clinical situation. ECG reassessment is necessary, and repeat administration may be required if serious abnormalities persist or recur.

Calcium should not be considered a complete treatment. Measures to shift and remove potassium must also be addressed.

C. Insulin and glucose

Insulin stimulates cellular uptake of potassium, temporarily lowering its concentration in the extracellular fluid.

Because insulin can cause hypoglycemia, intravenous glucose is commonly given alongside it when appropriate. The exact insulin and glucose regimen depends on the patient's circumstances and the local protocol.

Blood glucose must be monitored after treatment because hypoglycemia can develop later, particularly in patients with kidney dysfunction.

Potassium should also be rechecked to evaluate the response and detect rebound elevation.

D. Beta-2 adrenergic agonists

Beta-2 agonists, such as nebulized salbutamol (albuterol), can promote movement of potassium into cells.

They may be used alongside insulin and glucose because the mechanisms are complementary. The response varies, and beta-2 agonists should not be relied upon as the sole treatment for severe hyperkalemia.

Possible adverse effects include tremor, palpitations, and tachycardia. Their use should be individualized, especially in patients with cardiac conditions.

E. Sodium bicarbonate

Sodium bicarbonate may be considered in selected patients with significant metabolic acidosis.

Its potassium-lowering effect is inconsistent, and it is not recommended as a routine substitute for more established measures in every case of hyperkalemia.

The decision depends on the acid-base disturbance, fluid status, sodium balance, and overall clinical condition.

F. Potassium removal

Shifting potassium into cells provides temporary protection, but the body must also eliminate excess potassium.

Potential strategies include the following.

1. Diuretics

Loop diuretics may increase urinary potassium excretion when kidney function and urine production are sufficient. Their usefulness depends on volume status, renal function, and the underlying cause.

They are not appropriate as a stand-alone solution for every patient.

2. Potassium binders

Potassium-binding medicines act in the gastrointestinal tract to increase potassium removal through the bowel.

Examples include sodium zirconium cyclosilicate and patiromer. Sodium polystyrene sulfonate is another binder used in selected settings, although its onset, effectiveness, and gastrointestinal risks must be considered.

These agents differ in their onset of action, dosing, adverse effects, and suitability for acute versus chronic management. They should not delay emergency stabilization in life-threatening hyperkalemia.

3. Dialysis

Hemodialysis can remove potassium directly from the blood and is particularly important for patients with severe or persistent hyperkalemia, advanced kidney failure, or inadequate response to medical treatment.

Urgent dialysis may be required when potassium remains dangerously elevated, when kidney failure severely limits excretion, or when serious complications cannot be controlled with other measures.

The need and timing of dialysis depend on the entire clinical picture rather than a potassium value alone.

G. Monitoring after emergency treatment

Treatment does not end when the first potassium measurement improves.

The clinical team should reassess:

• Serum potassium.
• ECG and cardiac rhythm.
• Blood glucose after insulin treatment.
• Kidney function.
• Urine output and fluid status.
• Acid-base status when relevant.
• The possibility of rebound hyperkalemia.

Insulin and beta-2 agonists redistribute potassium rather than remove it. If the excess potassium has not been eliminated, the blood concentration may rise again as these temporary effects wear off.

Frequent reassessment is therefore essential.